Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6680
-0.0530 (-7.35%)
At close: May 13, 2025, 4:00 PM
0.7153
+0.0473 (7.08%)
Pre-market: May 14, 2025, 6:45 AM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $55.25 million as of May 14, 2025. Its market cap has decreased by -62.85% in one year.
Market Cap
55.25M
Enterprise Value
-78.94M
1-Year Change
-62.85%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $55.25M, a decrease of -81.69%. That is a compound annual growth rate of -30.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 59.63M | -24.77% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |